Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): David Raben (Chief Medical Officer): Grant/Award of 575,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | David Raben, Chief Medical Officer | Grant/Award | 575,000 | n/a |
| Jul 13, 2026 | Robert Iannone | Grant/Award | 60,000 | n/a |
| Jul 13, 2026 | Flavia Borellini | Grant/Award | 60,000 | n/a |
| Jun 12, 2026 | Gayle A. Crowell | Grant/Award | 70,000 | n/a |
| Jun 12, 2026 | Thomas A. Mccourt | Grant/Award | 70,000 | n/a |
| Jun 12, 2026 | Steve E. Krognes | Grant/Award | 70,000 | n/a |
| Jun 12, 2026 | John T. Curnutte | Grant/Award | 70,000 | n/a |
| Jun 12, 2026 | Hoyoung Huh | Grant/Award | 70,000 | n/a |
| Jun 12, 2026 | Darren S. Cline | Grant/Award | 70,000 | n/a |
| Apr 17, 2026 | Minnie Kuo, Chief Operating Officer | Disposition to Issuer | 150,000 | n/a |